BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18772059)

  • 1. Optimal medical therapy is a proven option for chronic stable angina.
    O'Rourke RA
    J Am Coll Cardiol; 2008 Sep; 52(11):905-7. PubMed ID: 18772059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of the BARI 2D and COURAGE trials: the evolving role of percutaneous coronary intervention.
    Holper EM; Addo T
    Coron Artery Dis; 2010 Nov; 21(7):397-401. PubMed ID: 20634692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial.
    Teo KK; Sedlis SP; Boden WE; O'Rourke RA; Maron DJ; Hartigan PM; Dada M; Gupta V; Spertus JA; Kostuk WJ; Berman DS; Shaw LJ; Chaitman BR; Mancini GB; Weintraub WS;
    J Am Coll Cardiol; 2009 Sep; 54(14):1303-8. PubMed ID: 19778673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial Veterans Affairs Cooperative Studies Program no. 424.
    Boden WE; O'rourke RA; Teo KK; Hartigan PM; Maron DJ; Kostuk W; Knudtson M; Dada M; Casperson P; Harris CL; Spertus JA; Shaw L; Chaitman BR; Mancini GB; Berman DS; Weintraub WS;
    Am Heart J; 2006 Jun; 151(6):1173-9. PubMed ID: 16781214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent changes in practice of elective percutaneous coronary intervention for stable angina.
    Ahmed B; Dauerman HL; Piper WD; Robb JF; Verlee MP; Ryan TJ; Goldberg D; Boss RA; Phillips WJ; Fedele F; Butzel D; Malenka DJ;
    Circ Cardiovasc Qual Outcomes; 2011 May; 4(3):300-5. PubMed ID: 21505155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of four randomized controlled trials on long-term outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with stenting for multivessel coronary artery disease.
    Takagi H; Kawai N; Umemoto T
    Am J Cardiol; 2008 May; 101(9):1259-62. PubMed ID: 18435954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes following percutaneous coronary intervention in patients previously considered "without option": a subgroup analysis of the PACIFIC Trial.
    Lowe HC; Oesterle SN; He KL; Macneill BD; Burkhoff D
    J Interv Cardiol; 2004 Apr; 17(2):87-91. PubMed ID: 15104770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE Trial).
    Boden WE; O'Rourke RA; Teo KK; Maron DJ; Hartigan PM; Sedlis SP; Dada M; Labedi M; Spertus JA; Kostuk WJ; Berman DS; Shaw LJ; Chaitman BR; Mancini GB; Weintraub WS;
    Am J Cardiol; 2009 Jul; 104(1):1-4. PubMed ID: 19576311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving concepts in selecting optimal strategies for the management of patients with stable coronary disease: pharmacologic or revascularization therapy.
    Tandar A; Boden WE
    Curr Opin Cardiol; 2009 Nov; 24(6):591-5. PubMed ID: 19752728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease.
    Schömig A; Mehilli J; de Waha A; Seyfarth M; Pache J; Kastrati A
    J Am Coll Cardiol; 2008 Sep; 52(11):894-904. PubMed ID: 18772058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial.
    Maron DJ; Spertus JA; Mancini GB; Hartigan PM; Sedlis SP; Bates ER; Kostuk WJ; Dada M; Berman DS; Shaw LJ; Chaitman BR; Teo KK; O'Rourke RA; Weintraub WS; Boden WE;
    Am J Cardiol; 2009 Oct; 104(8):1055-62. PubMed ID: 19801024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous coronary intervention in chronic kidney disease patients.
    Tadros GM; Herzog CA
    J Nephrol; 2004; 17(3):364-8. PubMed ID: 15365955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The place of metabolic agents in the management of stable angina pectoris.
    Jackson G
    Rev Port Cardiol; 1999 Sep; 18 Suppl 4():IV23-7. PubMed ID: 10555450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of revascularization on mortality in patients with nonacute coronary artery disease.
    Jeremias A; Kaul S; Rosengart TK; Gruberg L; Brown DL
    Am J Med; 2009 Feb; 122(2):152-61. PubMed ID: 19185092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost-effectiveness of percutaneous coronary intervention as a function of angina severity in patients with stable angina.
    Zhang Z; Kolm P; Boden WE; Hartigan PM; Maron DJ; Spertus JA; O'Rourke RA; Shaw LJ; Sedlis SP; Mancini GB; Berman DS; Dada M; Teo KK; Weintraub WS
    Circ Cardiovasc Qual Outcomes; 2011 Mar; 4(2):172-82. PubMed ID: 21304091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aggressive medical therapy for stable coronary disease: with or without percutaneous coronary intervention (COURAGE trial)].
    Manigold T; Gosselin G
    Rev Med Suisse; 2008 May; 4(159):1332-4, 1337. PubMed ID: 18592725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
    Motovska Z; Kala P
    Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COURAGE under fire: on the management of stable coronary disease.
    Diamond GA; Kaul S
    J Am Coll Cardiol; 2007 Oct; 50(16):1604-9. PubMed ID: 17936162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmyocardial laser revascularization as an adjunct to coronary artery bypass grafting.
    Allen KB
    Semin Thorac Cardiovasc Surg; 2006; 18(1):52-7. PubMed ID: 16766255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of 5-year outcomes of CABG vs PCI with stenting in patients with multivessel disease.
    Athappan G; Vinodhkumaradithyaa A; Srinivasan M; Jeyaseelan L; Ponniah T
    Minerva Cardioangiol; 2008 Oct; 56(5):453-60. PubMed ID: 18813180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.